Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-25 @ 9:01 PM
Study NCT ID:
NCT01436656
Status:
COMPLETED
Last Update Posted:
2024-10-28
First Post:
2011-04-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2012-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-14
First Submit QC Date:
None
Study First Post Date:
2011-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-11-03
Results First Submit QC Date:
None
Results First Post Date:
2024-10-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-13
Last Update Post Date:
2024-10-28
Last Update Post Date Type:
ACTUAL